Home > Boards > US Listed > Biotechs > Chimerix, Inc. (CMRX)

Big pharma’s billion-dollar bets

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stockguard Member Profile
 
Followed By 17
Posts 1,459
Boards Moderated 0
Alias Born 07/09/05
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/2/2020 4:07:28 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 9/30/2020 9:57:20 AM
Chimerix to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 9/10/2020 8:00:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/21/2020 4:31:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2020 5:35:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/11/2020 5:50:45 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/11/2020 8:20:53 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/10/2020 5:54:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2020 4:39:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 7:18:40 AM
Chimerix Reports Second Quarter 2020 Financial Results and Provides Operational Update GlobeNewswire Inc. - 8/10/2020 7:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/6/2020 12:55:52 PM
Chimerix to Report Second Quarter 2020 Financial Results and Provide an Operational Update on August 10, 2020 GlobeNewswire Inc. - 8/3/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 1:02:59 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/23/2020 1:00:23 PM
Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer GlobeNewswire Inc. - 6/22/2020 7:00:10 AM
Chimerix to Present at H.C. Wainwright Virtual Fireside Chat Series GlobeNewswire Inc. - 6/18/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/15/2020 1:18:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 12:49:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 12:45:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 12:44:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 12:43:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 12:41:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 12:41:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2020 12:39:27 PM
stockguard   Friday, 06/14/19 04:22:17 PM
Re: None
Post # of 625 
Big pharma’s billion-dollar bets
As patents lapse and funding on R&D is cut, big pharma is spending big money on risky takeovers to find the next blockbuster drug. In this animated film, Due Diligence's Arash Massoudi explains how Bristol-Myers Squibb’s $90B takeover of Celgene has set the stage for more to come in 2019.
As investors have exerted pressure on big pharma to cut back spending on research and development that can result in expensive disappointments, incumbents have been acquiring smaller competitors to replenish drug pipelines.
Nimble start-ups, in contrast, are not weighed down by legacy businesses and can focus on innovation. Many fail but those that succeed, or even show promise by producing just one drug, instantly become takeover targets.
Underpinning these acquisitions is a gamble. Should a big company buy a start-up that has potential but has not proven its worth? Or wait and miss out on a short cut to high returns and new products?

https://bigdeal.ft.com/videos/big-pharmas-billion-dollar-bets/?utm_source=TW&utm_medium=publishers&utm_content=image_card

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences